SCOTTSDALE, Ariz. (BUSINESS WIRE) Oligon™ Inc., an emerging biotechnology company developing a novel class of multimodal RNA therapeutics for the treatment of cancer and other diseases, announced today that Dr. Spyro Mousses, CEO and Co-Founder, Andrew Matricaria, CFO, and James Silver, COO, will participate in th.